Lones M A, Lopez-Terrada D, Shintaku I P, Rosenthal J, Said J W
Department of Pathology, Children's Hospital Orange County/St Joseph Hospital, Calif, USA.
Arch Pathol Lab Med. 1998 Aug;122(8):708-14.
Posttransplant lymphoproliferative disorders in bone marrow transplantation are typically rapidly progressive and fatal B-cell lymphoid proliferations associated with Epstein-Barr virus, and are mostly of donor origin. We report three pediatric bone marrow transplant cases in which posttransplant lymphoproliferative disorder was diagnosed at postmortem examination. Epstein-Barr virus in these cases was identified by a combined in situ hybridization-immunoperoxidase technique and donor origin was identified by fluorescence in situ hybridization.
Tissues obtained from postmortem examination were evaluated by light microscopy, immunohistochemistry, combined in situ hybridization-immunoperoxidase technique with Epstein-Barr virus-encoded RNA probe, and fluorescence in situ hybridization with X and Y centromeric probes.
Three pediatric patients underwent sex-mismatched, T-cell-depleted bone marrow transplants complicated by graft versus host disease, rapidly progressive multiple organ failure, and postmortem diagnosis of posttransplant lymphoproliferative disorder. Histologic examination and immunohistochemistry studies demonstrated immunoblastic lymphoma (one case) or polymorphic B-cell lymphoma (two cases). In all cases, Epstein-Barr virus-encoded RNA was detected by a combined in situ hybridization-immunoperoxidase technique. Fluorescence in situ hybridization for X and Y chromosomes in paraffin sections demonstrated donor origin in two cases (one case was indeterminate).
Fluorescence in situ hybridization was used to prove donor derivation of Epstein-Barr virus-associated posttransplant lymphoproliferative disorders in pediatric bone marrow transplant recipients. Many features of posttransplant lymphoproliferative disorders in pediatric bone marrow transplant recipients are very similar to adult cases, although a higher proportion of children appear to be diagnosed postmortem and have a fatal outcome.
骨髓移植后的移植后淋巴细胞增殖性疾病通常是与爱泼斯坦-巴尔病毒相关的快速进展且致命的B细胞淋巴增殖性疾病,且大多起源于供体。我们报告了3例儿科骨髓移植病例,这些病例在尸检时被诊断为移植后淋巴细胞增殖性疾病。通过原位杂交-免疫过氧化物酶联合技术鉴定这些病例中的爱泼斯坦-巴尔病毒,并通过荧光原位杂交鉴定供体来源。
对尸检获得的组织进行光学显微镜检查、免疫组织化学检查、使用爱泼斯坦-巴尔病毒编码RNA探针的原位杂交-免疫过氧化物酶联合技术检查,以及使用X和Y着丝粒探针进行荧光原位杂交检查。
3例儿科患者接受了性别不匹配、T细胞去除的骨髓移植,并发移植物抗宿主病、快速进展的多器官衰竭,并在尸检时诊断为移植后淋巴细胞增殖性疾病。组织学检查和免疫组织化学研究显示为免疫母细胞淋巴瘤(1例)或多形性B细胞淋巴瘤(2例)。在所有病例中,通过原位杂交-免疫过氧化物酶联合技术检测到爱泼斯坦-巴尔病毒编码RNA。石蜡切片中X和Y染色体的荧光原位杂交显示2例起源于供体(1例不确定)。
荧光原位杂交用于证实儿科骨髓移植受者中与爱泼斯坦-巴尔病毒相关的移植后淋巴细胞增殖性疾病的供体来源。儿科骨髓移植受者移植后淋巴细胞增殖性疾病的许多特征与成人病例非常相似,尽管儿童中更高比例的病例似乎是在尸检时被诊断出来的,并且预后不良。